Equities

OpGen Inc

OpGen Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.64
  • Today's Change-0.060 / -2.23%
  • Shares traded12.74k
  • 1 Year change-57.46%
  • Beta-0.6381
Data delayed at least 15 minutes, as of Jun 07 2024 20:39 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

  • Revenue in USD (TTM)3.07m
  • Net income in USD-26.16m
  • Incorporated2001
  • Employees100.00
  • Location
    OpGen Inc9717 Key West Avenue, Suite 100ROCKVILLE 20850United StatesUSA
  • Phone+1 (301) 869-9683
  • Fax+1 (301) 869-9684
  • Websitehttps://opgen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modern Mobility Aids Inc0.00-1.59m1.80m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
Ethema Health Corp5.34m1.13m1.86m65.001.79--1.280.34880.00030.00030.0014-0.00170.5912--16.4482,230.4611.13-37.68--------18.83-94.87---0.61875.04--10.8765.34652.41--74.97--
CompuMed Inc1.78m-151.00k2.37m8.00--18.21--1.33-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Mitesco Inc0.00-10.91m2.37m3.00---------1.91-1.940.00-2.600.00----0.00-10,172.81-246.54-----------29,214.62---0.1207---------59.12------
IMD Companies Inc439.50k-330.55k2.46m3.00------5.61-0.0053-0.00530.0049-0.00210.430331.325.58146,500.00-32.36-41.61-43.47-58.1633.5249.68-75.21-89.491.05--1.48--26.65---47.11------
Dror Ortho-Design Inc0.00-4.83m2.97m4.00--8.17-----0.0115-0.01150.000.00070.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
IMAC Holdings Inc0.00-5.63m3.19m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
OpGen Inc3.07m-26.16m3.42m100.00--1.01--1.11-65.10-65.105.502.670.12022.915.6430,702.30-102.41-79.05-196.63-110.126.6222.60-852.12-706.290.1809-7.530.7746---39.45-4.0811.17--16.36--
Greenbrook TMS Inc72.49m-52.54m4.66m629.00------0.0643-1.24-1.241.71-2.450.9471--6.22---69.41-68.51-113.55-106.4525.9238.65-73.29-76.82---2.40136.38--10.4228.2644.21---54.79--
Assure Holdings Corp255.00k-21.45m4.81m95.00------18.85-3.80-4.600.055-2.280.0161--0.02722,684.21-135.04-35.15-937.78-46.37-860.3937.14-8,410.59-116.06---5.92-----45.86-55.626.19------
Data as of Jun 07 2024. Currency figures normalised to OpGen Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.